Suppr超能文献

从血浆中去除血红蛋白:对镰状细胞病和其他溶血性过程中蛋白质组学发现的考虑。

Hemoglobin depletion from plasma: considerations for proteomic discovery in sickle cell disease and other hemolytic processes.

机构信息

Department Pediatrics, Division of Pediatric Hematology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

Proteomics Clin Appl. 2010 Dec;4(12):926-30. doi: 10.1002/prca.201000054.

Abstract

PURPOSE

Hemoglobin (Hb) depletion with nickel affinity chromatography has been shown to increase the number of proteins identified in proteomic studies of erythrocytes, but limited data exist on the application of this technique in depletion of Hb from plasma or serum required for clinical biomarker studies. The aim of this study was to explore the potential of using nickel-beads for Hb depletion of plasma.

EXPERIMENTAL DESIGN

Nickel–nitrilotriacetic acid (Ni–NTA) affinity chromatography was used to deplete Hb from hemolyzed plasma samples obtained from children with sickle cell disease (SCD, n=7) and normal human plasma (n=4). Ni–NTA-bound proteins were analyzed by one-dimensional GE, followed by in-gel digestion for characterization using an LTQ-Orbitrap hybrid mass spectrometer. In addition, the loss of two non-Hb-related plasma proteins, thrombospondin1 and L-selectin, by Ni–NTA was determined by ELISA (SCD n=6, non-SCD controls n=2).

RESULTS

Ni–NTA resulted in an average 60% decrease in plasma protein concentration, which was not hemolysis dependent. Specifically, Hb (7 peptides) and the top three proteins, -2-macroglobulin (75 peptides), apolipoprotein B-100 (73 peptides), and albumin (42 peptides) were Ni–NTA bound. In addition, using an ELISA assay two non-Hb-associated plasma proteins thrombospondin1 and L-selectin were decreased by Ni-NTA.

CONCLUSIONS AND CLINICAL RELEVANCE

Hb depletion with Ni–NTA is effective for Hb removal but is not specific. There is a potential for deleterious depletion of potential biomarkers that may limit the applicability of this method. Consideration of alternate methods of Hb depletion for clinical proteomics may be warranted.

摘要

目的

镍亲和层析法去除血红蛋白(Hb)已被证明可增加红细胞蛋白质组学研究中鉴定的蛋白质数量,但关于该技术在从血浆或血清中去除 Hb 以进行临床生物标志物研究的应用,数据有限。本研究旨在探索使用镍珠从血浆中去除 Hb 的潜力。

实验设计

使用镍-亚氨基二乙酸(Ni-NTA)亲和层析法从镰状细胞病(SCD,n=7)患儿的溶血血浆样本和正常人血浆(n=4)中去除 Hb。通过一维凝胶电泳(1DGE)分析 Ni-NTA 结合的蛋白质,然后通过胶内消化,使用 LTQ-Orbitrap 杂交质谱仪进行鉴定。此外,通过 ELISA(SCD n=6,非 SCD 对照组 n=2)测定 Ni-NTA 对两种非 Hb 相关血浆蛋白,即血小板反应蛋白 1(TSP1)和 L-选择素(L-selectin)的损失。

结果

Ni-NTA 导致血浆蛋白浓度平均降低 60%,且不依赖于溶血。具体来说,Hb(7 个肽段)和前三个蛋白,-2-巨球蛋白(75 个肽段)、载脂蛋白 B-100(73 个肽段)和白蛋白(42 个肽段)与 Ni-NTA 结合。此外,通过 ELISA 检测,两种非 Hb 相关的血浆蛋白血小板反应蛋白 1(TSP1)和 L-选择素(L-selectin)也被 Ni-NTA 消耗。

结论和临床相关性

Ni-NTA 去除 Hb 是有效的,但不具有特异性。有可能会消耗掉潜在的生物标志物,从而限制该方法的适用性。考虑替代方法去除 Hb 用于临床蛋白质组学可能是必要的。

相似文献

3
Development and characterization of Ni-NTA-bearing microspheres.
Cytometry. 2002 Jul 1;48(3):136-45. doi: 10.1002/cyto.10124.
5
Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease.
Proteomics Clin Appl. 2021 Sep;15(5):e2100003. doi: 10.1002/prca.202100003. Epub 2021 May 24.
6
Ni-NTA-gold clusters target His-tagged proteins.
J Struct Biol. 1999 Sep;127(2):185-98. doi: 10.1006/jsbi.1999.4149.
7
Inflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 Protein.
PLoS One. 2016 Nov 1;11(11):e0165833. doi: 10.1371/journal.pone.0165833. eCollection 2016.
8
Hexahistidine-tag-specific optical probes for analyses of proteins and their interactions.
Anal Biochem. 2010 Apr 15;399(2):237-45. doi: 10.1016/j.ab.2009.12.028. Epub 2009 Dec 28.

引用本文的文献

1
Evidence for low-level translation in human erythrocytes.
Mol Biol Cell. 2022 Oct 1;33(12):br21. doi: 10.1091/mbc.E21-09-0437. Epub 2022 Aug 17.
2
Proteomic discovery in sickle cell disease: Elevated neurogranin levels in children with sickle cell disease.
Proteomics Clin Appl. 2021 Sep;15(5):e2100003. doi: 10.1002/prca.202100003. Epub 2021 May 24.
3
Comparison of the RNA Content of Extracellular Vesicles Derived from and .
Cells. 2019 Jul 23;8(7):765. doi: 10.3390/cells8070765.
4
Maximizing peptide identification events in proteomic workflows using data-dependent acquisition (DDA).
Mol Cell Proteomics. 2014 Jan;13(1):329-38. doi: 10.1074/mcp.M112.026500. Epub 2013 Jul 2.

本文引用的文献

1
Design of the silent cerebral infarct transfusion (SIT) trial.
Pediatr Hematol Oncol. 2010 Mar;27(2):69-89. doi: 10.3109/08880010903360367.
2
Role of spectral counting in quantitative proteomics.
Expert Rev Proteomics. 2010 Feb;7(1):39-53. doi: 10.1586/epr.09.69.
3
Thrombospondins function as regulators of angiogenesis.
J Cell Commun Signal. 2009 Dec;3(3-4):189-200. doi: 10.1007/s12079-009-0060-8. Epub 2009 Oct 2.
4
A guide to the Proteomics Identifications Database proteomics data repository.
Proteomics. 2009 Sep;9(18):4276-83. doi: 10.1002/pmic.200900402.
5
Significance analysis of spectral count data in label-free shotgun proteomics.
Mol Cell Proteomics. 2008 Dec;7(12):2373-85. doi: 10.1074/mcp.M800203-MCP200. Epub 2008 Jul 20.
6
Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy.
Mol Cell Proteomics. 2008 Oct;7(10):1963-73. doi: 10.1074/mcp.M800008-MCP200. Epub 2008 Jul 15.
8
A network model to predict the risk of death in sickle cell disease.
Blood. 2007 Oct 1;110(7):2727-35. doi: 10.1182/blood-2007-04-084921. Epub 2007 Jun 28.
9
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation.
Blood. 2007 Mar 1;109(5):1945-52. doi: 10.1182/blood-2006-08-041368. Epub 2006 Nov 2.
10
Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways.
Circ Res. 2006 Sep 29;99(7):706-14. doi: 10.1161/01.RES.0000243995.74395.f8. Epub 2006 Aug 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验